1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Brain Ischemia Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Anticoagulation Therapy 1.2.3 Antiplatelet 1.2.4 Other 1.3 Market by Application 1.3.1 Global Brain Ischemia Market Growth Rate by Application: 2017 VS 2021 VS 2028 1.3.2 Hospital 1.3.3 Clinics 1.3.4 Other 1.4 Study Objectives 1.5 Years Considered 2 Market Perspective 2.1 Global Brain Ischemia Market Size (2017-2028) 2.2 Brain Ischemia Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028 2.3 Global Brain Ischemia Market Size by Region (2017-2022) 2.4 Global Brain Ischemia Market Size Forecast by Region (2023-2028) 2.5 Global Top Brain Ischemia Countries Ranking by Market Size 3 Brain Ischemia Competitive by Company 3.1 Global Brain Ischemia Revenue by Players 3.1.1 Global Brain Ischemia Revenue by Players (2017-2022) 3.1.2 Global Brain Ischemia Market Share by Players (2017-2022) 3.2 Global Brain Ischemia Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Company Covered: Ranking by Brain Ischemia Revenue 3.4 Global Brain Ischemia Market Concentration Ratio 3.4.1 Global Brain Ischemia Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Brain Ischemia Revenue in 2021 3.5 Global Brain Ischemia Key Players Head office and Area Served 3.6 Key Players Brain Ischemia Product Solution and Service 3.7 Date of Enter into Brain Ischemia Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Global Brain Ischemia Breakdown Data by Type 4.1 Global Brain Ischemia Historic Revenue by Type (2017-2022) 4.2 Global Brain Ischemia Forecasted Revenue by Type (2023-2028) 5 Global Brain Ischemia Breakdown Data by Application 5.1 Global Brain Ischemia Historic Market Size by Application (2017-2022) 5.2 Global Brain Ischemia Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Brain Ischemia Revenue by Company (2020-2022) 6.2 North America Brain Ischemia Revenue by Type (2017-2028) 6.3 North America Brain Ischemia Revenue by Application (2017-2028) 6.4 North America Brain Ischemia Revenue by Country (2017-2028) 6.4.1 U.S. 6.4.2 Canada 7 Europe 7.1 Europe Brain Ischemia Revenue by Company (2020-2022) 7.2 Europe Brain Ischemia Revenue by Type (2017-2028) 7.3 Europe Brain Ischemia Revenue by Application (2017-2028) 7.4 Europe Brain Ischemia Revenue by Country (2017-2028) 7.4.1 Germany 7.4.2 France 7.4.3 U.K. 7.4.4 Italy 7.4.5 Russia 8 Asia Pacific 8.1 Asia Pacific Brain Ischemia Revenue by Company (2020-2022) 8.2 Asia Pacific Brain Ischemia Revenue by Type (2017-2028) 8.3 Asia Pacific Brain Ischemia Revenue by Application (2017-2028) 8.4 Asia Pacific Brain Ischemia Revenue by Region (2017-2028) 8.4.1 China 8.4.2 Japan 8.4.3 South Korea 8.4.4 India 8.4.5 Australia 8.4.6 Taiwan 8.4.7 Indonesia 8.4.8 Thailand 8.4.9 Malaysia 8.4.10 Philippines 8.4.11 Vietnam 9 Latin America 9.1 Latin America Brain Ischemia Revenue by Company (2020-2022) 9.2 Latin America Brain Ischemia Revenue by Type (2017-2028) 9.3 Latin America Brain Ischemia Revenue by Application (2017-2028) 9.4 Latin America Brain Ischemia Revenue by Country (2017-2028) 9.4.1 Mexico 9.4.2 Brazil 9.4.3 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Brain Ischemia Revenue by Company (2020-2022) 10.2 Middle East and Africa Brain Ischemia Revenue by Type (2017-2028) 10.3 Middle East and Africa Brain Ischemia Revenue by Application (2017-2028) 10.4 Middle East and Africa Brain Ischemia Revenue by Country (2017-2028) 10.4.1 Turkey 10.4.2 Saudi Arabia 10.4.3 U.A.E 11 Company Profiles 11.1 Bayer AG 11.1.1 Bayer AG Company Details 11.1.2 Bayer AG Business Overview 11.1.3 Bayer AG Brain Ischemia Products and Services 11.1.4 Bayer AG Brain Ischemia Revenue in Brain Ischemia Business (2017-2022) 11.1.5 Bayer AG Brain Ischemia SWOT Analysis 11.1.6 Bayer AG Recent Developments 11.2 H. Lundbeck 11.2.1 H. Lundbeck Company Details 11.2.2 H. Lundbeck Business Overview 11.2.3 H. Lundbeck Brain Ischemia Products and Services 11.2.4 H. Lundbeck Brain Ischemia Revenue in Brain Ischemia Business (2017-2022) 11.2.5 H. Lundbeck Brain Ischemia SWOT Analysis 11.2.6 H. Lundbeck Recent Developments 11.3 Bristol-Myers Squibb 11.3.1 Bristol-Myers Squibb Company Details 11.3.2 Bristol-Myers Squibb Business Overview 11.3.3 Bristol-Myers Squibb Brain Ischemia Products and Services 11.3.4 Bristol-Myers Squibb Brain Ischemia Revenue in Brain Ischemia Business (2017-2022) 11.3.5 Bristol-Myers Squibb Brain Ischemia SWOT Analysis 11.3.6 Bristol-Myers Squibb Recent Developments 11.4 Boehringer Ingelheim 11.4.1 Boehringer Ingelheim Company Details 11.4.2 Boehringer Ingelheim Business Overview 11.4.3 Boehringer Ingelheim Brain Ischemia Products and Services 11.4.4 Boehringer Ingelheim Brain Ischemia Revenue in Brain Ischemia Business (2017-2022) 11.4.5 Boehringer Ingelheim Brain Ischemia SWOT Analysis 11.4.6 Boehringer Ingelheim Recent Developments 11.5 ThromboGenics 11.5.1 ThromboGenics Company Details 11.5.2 ThromboGenics Business Overview 11.5.3 ThromboGenics Brain Ischemia Products and Services 11.5.4 ThromboGenics Brain Ischemia Revenue in Brain Ischemia Business (2017-2022) 11.5.5 ThromboGenics Brain Ischemia SWOT Analysis 11.5.6 ThromboGenics Recent Developments 11.6 Vernalis 11.6.1 Vernalis Company Details 11.6.2 Vernalis Business Overview 11.6.3 Vernalis Brain Ischemia Products and Services 11.6.4 Vernalis Brain Ischemia Revenue in Brain Ischemia Business (2017-2022) 11.6.5 Vernalis Brain Ischemia SWOT Analysis 11.6.6 Vernalis Recent Developments 11.7 Neurotec Pharma 11.7.1 Neurotec Pharma Company Details 11.7.2 Neurotec Pharma Business Overview 11.7.3 Neurotec Pharma Brain Ischemia Products and Services 11.7.4 Neurotec Pharma Brain Ischemia Revenue in Brain Ischemia Business (2017-2022) 11.7.5 Neurotec Pharma Brain Ischemia SWOT Analysis 11.7.6 Neurotec Pharma Recent Developments 11.8 Johnson and Johnson 11.8.1 Johnson and Johnson Company Details 11.8.2 Johnson and Johnson Business Overview 11.8.3 Johnson and Johnson Brain Ischemia Products and Services 11.8.4 Johnson and Johnson Brain Ischemia Revenue in Brain Ischemia Business (2017-2022) 11.8.5 Johnson and Johnson Brain Ischemia SWOT Analysis 11.8.6 Johnson and Johnson Recent Developments 12 Brain Ischemia Market Dynamics 12.1 Brain Ischemia Market Trends 12.2 Brain Ischemia Market Drivers 12.3 Brain Ischemia Market Challenges 12.4 Brain Ischemia Market Restraints 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.2 Data Source 14.2 Author Details

List of Tables Table 1. Global Brain Ischemia Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Anticoagulation Therapy Table 3. Key Players of Antiplatelet Table 4. Key Players of Other Table 5. Global Brain Ischemia Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 6. Global Brain Ischemia Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028 Table 7. Global Brain Ischemia Revenue by Region (2017-2022) & (US$ Million) Table 8. Global Brain Ischemia Revenue Market Share by Region (2017-2022) Table 9. Global Brain Ischemia Revenue by Players (2017-2022) & (US$ Million) Table 10. Global Brain Ischemia Market Share by Players (2017-2022) Table 11. Global Top Brain Ischemia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brain Ischemia as of 2021) Table 12. Ranking of Global Top Brain Ischemia Companies by Revenue (US$ Million) in 2021 Table 13. Global 5 Largest Players Market Share by Brain Ischemia Revenue (CR5 and HHI) & (2017-2022) Table 14. Key Players Headquarters and Area Served Table 15. Key Players Brain Ischemia Product Solution and Service Table 16. Date of Key Manufacturers Enter into Brain Ischemia Market Table 17. Mergers & Acquisitions, Expansion Plans Table 18. Global Brain Ischemia Market Size by Type (2017-2022) & (US$ Million) Table 19. Global Brain Ischemia Revenue Market Share by Type (2017-2022) Table 20. Global Brain Ischemia Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 21. Global Brain Ischemia Revenue Market Share by Type (2023-2028) Table 22. Global Brain Ischemia Market Size by Application (2017-2022) & (US$ Million) Table 23. Global Brain Ischemia Revenue Market Share by Application (2017-2022) Table 24. Global Brain Ischemia Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 25. Global Brain Ischemia Revenue Market Share by Application (2023-2028) Table 26. North America Brain Ischemia Revenue by Company (2020-2022) & (US$ Million) Table 27. North America Brain Ischemia Revenue by Type (2017-2022) & (US$ Million) Table 28. North America Brain Ischemia Revenue by Type (2023-2028) & (US$ Million) Table 29. North America Brain Ischemia Revenue by Application (2017-2022) & (US$ Million) Table 30. North America Brain Ischemia Revenue by Application (2023-2028) & (US$ Million) Table 31. North America Brain Ischemia Revenue by Country (2017-2022) & (US$ Million) Table 32. North America Brain Ischemia Revenue by Country (2023-2028) & (US$ Million) Table 33. Europe Brain Ischemia Revenue by Company (2020-2022) & (US$ Million) Table 34. Europe Brain Ischemia Revenue by Type (2017-2022) & (US$ Million) Table 35. Europe Brain Ischemia Revenue by Type (2023-2028) & (US$ Million) Table 36. Europe Brain Ischemia Revenue by Application (2017-2022) & (US$ Million) Table 37. Europe Brain Ischemia Revenue by Application (2023-2028) & (US$ Million) Table 38. Europe Brain Ischemia Revenue by Country (2017-2022) & (US$ Million) Table 39. Europe Brain Ischemia Revenue by Country (2023-2028) & (US$ Million) Table 40. Asia Pacific Brain Ischemia Revenue by Company (2020-2022) & (US$ Million) Table 41. Asia Pacific Brain Ischemia Revenue by Type (2017-2022) & (US$ Million) Table 42. Asia Pacific Brain Ischemia Revenue by Type (2023-2028) & (US$ Million) Table 43. Asia Pacific Brain Ischemia Revenue by Application (2017-2022) & (US$ Million) Table 44. Asia Pacific Brain Ischemia Revenue by Application (2023-2028) & (US$ Million) Table 45. Asia Pacific Brain Ischemia Revenue by Region (2017-2022) & (US$ Million) Table 46. Asia Pacific Brain Ischemia Revenue by Region (2023-2028) & (US$ Million) Table 47. Latin America Brain Ischemia Revenue by Company (2020-2022) & (US$ Million) Table 48. Latin America Brain Ischemia Revenue by Type (2017-2022) & (US$ Million) Table 49. Latin America Brain Ischemia Revenue by Type (2023-2028) & (US$ Million) Table 50. Latin America Brain Ischemia Revenue by Application (2017-2022) & (US$ Million) Table 51. Latin America Brain Ischemia Revenue by Application (2023-2028) & (US$ Million) Table 52. Latin America Brain Ischemia Revenue by Country (2017-2022) & (US$ Million) Table 53. Latin America Brain Ischemia Revenue by Country (2023-2028) & (US$ Million) Table 54. Middle East and Africa Brain Ischemia Revenue by Company (2020-2022) & (US$ Million) Table 55. Middle East and Africa Brain Ischemia Revenue by Type (2017-2022) & (US$ Million) Table 56. Middle East and Africa Brain Ischemia Revenue by Type (2023-2028) & (US$ Million) Table 57. Middle East and Africa Brain Ischemia Revenue by Application (2017-2022) & (US$ Million) Table 58. Middle East and Africa Brain Ischemia Revenue by Application (2023-2028) & (US$ Million) Table 59. Middle East and Africa Brain Ischemia Revenue by Country (2017-2022) & (US$ Million) Table 60. Middle East and Africa Brain Ischemia Revenue by Country (2023-2028) & (US$ Million) Table 61. Bayer AG Company Details Table 62. Bayer AG Business Overview Table 63. Bayer AG Brain Ischemia Product and Services Table 64. Bayer AG Brain Ischemia Revenue in Brain Ischemia Business (2017-2022) & (US$ Million) Table 65. Bayer AG Brain Ischemia SWOT Analysis Table 66. Bayer AG Recent Developments Table 67. H. Lundbeck Company Details Table 68. H. Lundbeck Business Overview Table 69. H. Lundbeck Brain Ischemia Product and Services Table 70. H. Lundbeck Brain Ischemia Revenue in Brain Ischemia Business (2017-2022) & (US$ Million) Table 71. H. Lundbeck Brain Ischemia SWOT Analysis Table 72. H. Lundbeck Recent Developments Table 73. Bristol-Myers Squibb Company Details Table 74. Bristol-Myers Squibb Business Overview Table 75. Bristol-Myers Squibb Brain Ischemia Product and Services Table 76. Bristol-Myers Squibb Brain Ischemia Revenue in Brain Ischemia Business (2017-2022) & (US$ Million) Table 77. Bristol-Myers Squibb Brain Ischemia SWOT Analysis Table 78. Bristol-Myers Squibb Recent Developments Table 79. Boehringer Ingelheim Company Details Table 80. Boehringer Ingelheim Business Overview Table 81. Boehringer Ingelheim Brain Ischemia Product and Services Table 82. Boehringer Ingelheim Brain Ischemia Revenue in Brain Ischemia Business (2017-2022) & (US$ Million) Table 83. Boehringer Ingelheim Brain Ischemia SWOT Analysis Table 84. Boehringer Ingelheim Recent Developments Table 85. ThromboGenics Company Details Table 86. ThromboGenics Business Overview Table 87. ThromboGenics Brain Ischemia Product and Services Table 88. ThromboGenics Brain Ischemia Revenue in Brain Ischemia Business (2017-2022) & (US$ Million) Table 89. ThromboGenics Brain Ischemia SWOT Analysis Table 90. ThromboGenics Recent Developments Table 91. Vernalis Company Details Table 92. Vernalis Business Overview Table 93. Vernalis Brain Ischemia Product and Services Table 94. Vernalis Brain Ischemia Revenue in Brain Ischemia Business (2017-2022) & (US$ Million) Table 95. Vernalis Brain Ischemia SWOT Analysis Table 96. Vernalis Recent Developments Table 97. Neurotec Pharma Company Details Table 98. Neurotec Pharma Business Overview Table 99. Neurotec Pharma Brain Ischemia Product and Services Table 100. Neurotec Pharma Brain Ischemia Revenue in Brain Ischemia Business (2017-2022) & (US$ Million) Table 101. Neurotec Pharma Brain Ischemia SWOT Analysis Table 102. Neurotec Pharma Recent Developments Table 103. Johnson and Johnson Company Details Table 104. Johnson and Johnson Business Overview Table 105. Johnson and Johnson Brain Ischemia Product and Services Table 106. Johnson and Johnson Brain Ischemia Revenue in Brain Ischemia Business (2017-2022) & (US$ Million) Table 107. Johnson and Johnson Brain Ischemia SWOT Analysis Table 108. Johnson and Johnson Recent Developments Table 109. Brain Ischemia Market Trends Table 110. Brain Ischemia Market Drivers Table 111. Brain Ischemia Market Challenges Table 112. Brain Ischemia Market Restraints Table 113. Research Programs/Design for This Report Table 114. Key Data Information from Secondary Sources Table 115. Key Data Information from Primary Sources List of Figures Figure 1. Global Brain Ischemia Sales Market Share by Type: 2021 VS 2028 Figure 2. Anticoagulation Therapy Features Figure 3. Antiplatelet Features Figure 4. Other Features Figure 5. Global Brain Ischemia Sales Market Share by Application: 2021 VS 2028 Figure 6. Hospital Case Studies Figure 7. Clinics Case Studies Figure 8. Other Case Studies Figure 9. Brain Ischemia Report Years Considered Figure 10. Global Brain Ischemia Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 11. Global Brain Ischemia Market Size 2017-2028 (US$ Million) Figure 12. Global Brain Ischemia Market Size Market Share by Region: 2021 VS 2028 Figure 13. Global Brain Ischemia Revenue Market Share by Region in 2017 VS 2022 Figure 14. Global Top 10 Brain Ischemia Countries Ranking by Market Size (US$ Million) in 2021 Figure 15. Global Brain Ischemia Market Share by Players in 2021 Figure 16. Global Top Brain Ischemia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brain Ischemia as of 2021) Figure 17. The Top 10 and 5 Players Market Share by Brain Ischemia Revenue in 2021 Figure 18. North America Brain Ischemia Revenue Market Share by Company in 2021 Figure 19. North America Brain Ischemia Revenue Market Share by Type (2017-2028) Figure 20. North America Brain Ischemia Revenue Market Share by Application (2017-2028) Figure 21. North America Brain Ischemia Revenue Share by Country (2017-2028) Figure 22. U.S. Brain Ischemia Revenue (2017-2028) & (US$ Million) Figure 23. Canada Brain Ischemia Revenue (2017-2028) & (US$ Million) Figure 24. Europe Brain Ischemia Revenue Market Share by Company in 2021 Figure 25. Europe Brain Ischemia Revenue Market Share by Type (2017-2028) Figure 26. Europe Brain Ischemia Revenue Market Share by Application (2017-2028) Figure 27. Europe Brain Ischemia Revenue Share by Country (2017-2028) Figure 28. Germany Brain Ischemia Revenue (2017-2028) & (US$ Million) Figure 29. France Brain Ischemia Revenue (2017-2028) & (US$ Million) Figure 30. U.K. Brain Ischemia Revenue (2017-2028) & (US$ Million) Figure 31. Italy Brain Ischemia Revenue (2017-2028) & (US$ Million) Figure 32. Russia Brain Ischemia Revenue (2017-2028) & (US$ Million) Figure 33. Asia Pacific Brain Ischemia Revenue Market Share by Company in 2021 Figure 34. Asia Pacific Brain Ischemia Revenue Market Share by Type (2017-2028) Figure 35. Asia Pacific Brain Ischemia Revenue Market Share by Application (2017-2028) Figure 36. Asia Pacific Brain Ischemia Revenue Share by Region (2017-2028) Figure 37. China Brain Ischemia Revenue (2017-2028) & (US$ Million) Figure 38. Japan Brain Ischemia Revenue (2017-2028) & (US$ Million) Figure 39. South Korea Brain Ischemia Revenue (2017-2028) & (US$ Million) Figure 40. India Brain Ischemia Revenue (2017-2028) & (US$ Million) Figure 41. Australia Brain Ischemia Revenue (2017-2028) & (US$ Million) Figure 42. Taiwan Brain Ischemia Revenue (2017-2028) & (US$ Million) Figure 43. Indonesia Brain Ischemia Revenue (2017-2028) & (US$ Million) Figure 44. Thailand Brain Ischemia Revenue (2017-2028) & (US$ Million) Figure 45. Malaysia Brain Ischemia Revenue (2017-2028) & (US$ Million) Figure 46. Philippines Brain Ischemia Revenue (2017-2028) & (US$ Million) Figure 47. Vietnam Brain Ischemia Revenue (2017-2028) & (US$ Million) Figure 48. Latin America Brain Ischemia Revenue Market Share by Company in 2021 Figure 49. Latin America Brain Ischemia Revenue Market Share by Type (2017-2028) Figure 50. Latin America Brain Ischemia Revenue Market Share by Application (2017-2028) Figure 51. Latin America Brain Ischemia Revenue Share by Country (2017-2028) Figure 52. Mexico Brain Ischemia Revenue (2017-2028) & (US$ Million) Figure 53. Brazil Brain Ischemia Revenue (2017-2028) & (US$ Million) Figure 54. Argentina Brain Ischemia Revenue (2017-2028) & (US$ Million) Figure 55. Middle East and Africa Brain Ischemia Revenue Market Share by Company in 2021 Figure 56. Middle East and Africa Brain Ischemia Revenue Market Share by Type (2017-2028) Figure 57. Middle East and Africa Brain Ischemia Revenue Market Share by Application (2017-2028) Figure 58. Middle East and Africa Brain Ischemia Revenue Share by Country (2017-2028) Figure 59. Turkey Brain Ischemia Revenue (2017-2028) & (US$ Million) Figure 60. Saudi Arabia Brain Ischemia Revenue (2017-2028) & (US$ Million) Figure 61. U.A.E Brain Ischemia Revenue (2017-2028) & (US$ Million) Figure 62. Bayer AG Revenue Growth Rate in Brain Ischemia Business (2017-2022) Figure 63. H. Lundbeck Revenue Growth Rate in Brain Ischemia Business (2017-2022) Figure 64. Bristol-Myers Squibb Revenue Growth Rate in Brain Ischemia Business (2017-2022) Figure 65. Boehringer Ingelheim Revenue Growth Rate in Brain Ischemia Business (2017-2022) Figure 66. ThromboGenics Revenue Growth Rate in Brain Ischemia Business (2017-2022) Figure 67. Vernalis Revenue Growth Rate in Brain Ischemia Business (2017-2022) Figure 68. Neurotec Pharma Revenue Growth Rate in Brain Ischemia Business (2017-2022) Figure 69. Johnson and Johnson Revenue Growth Rate in Brain Ischemia Business (2017-2022) Figure 70. Bottom-up and Top-down Approaches for This Report Figure 71. Data Triangulation Figure 72. Key Executives Interviewed

Bayer AG H. Lundbeck Bristol-Myers Squibb Boehringer Ingelheim ThromboGenics Vernalis Neurotec Pharma Johnson and Johnson